Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

NCT06703606

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Brody School of Medicine at East Carolina University Greenville, North Carolina, United States
  • ECU Health Medical Center Greenville, North Carolina, United States
  • Nirmal Hospital Pvt Ltd. Surat, Gujarat, India
View Trial Details
Recruiting

Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis

NCT07612280

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +9 more
Locations
  • St. Vincent's Hospital Sydney Limited Sydney, New South Wales, Australia
  • Macquarie University Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • St Vincent's Hospital (Melbourne) Melbourne, Victoria, Australia
View Trial Details
Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

NCT05145400

Conditions
Blood Protein Disorders, Cancer, Cardiovascular Diseases, +13 more
Locations
  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Novant Health New Hanover Regional Medical Center Wilmington, North Carolina, United States
View Trial Details
Recruiting

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

NCT06539182

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Hefei, Anhui, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Guangzhou, Guandong, China
View all 17 locations
View Trial Details
Recruiting

Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA

NCT07620275

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University Beijing, China
  • National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, China
View Trial Details
Recruiting

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

NCT05557695

Conditions
Chronic Lymphocytic Leukemia, CLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Research Site Aylesbury, United Kingdom
  • Research Site Bath, United Kingdom
  • Research Site Birmingham, United Kingdom
  • Research Site Bournemouth, United Kingdom
View all 29 locations
View Trial Details

Related conditions